Cargando…
Voltage modulates halothane-triggered Ca(2+) release in malignant hyperthermia-susceptible muscle
Malignant hyperthermia (MH) is a fatal hypermetabolic state that may occur during general anesthesia in susceptible individuals. It is often caused by mutations in the ryanodine receptor RyR1 that favor drug-induced release of Ca(2+) from the sarcoplasmic reticulum. Here, knowing that membrane depol...
Autores principales: | Zullo, Alberto, Textor, Martin, Elischer, Philipp, Mall, Stefan, Alt, Andreas, Klingler, Werner, Melzer, Werner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749113/ https://www.ncbi.nlm.nih.gov/pubmed/29247050 http://dx.doi.org/10.1085/jgp.201711864 |
Ejemplares similares
-
Hypermetabolism in B–lymphocytes from malignant hyperthermia susceptible individuals
por: Hoppe, Kerstin, et al.
Publicado: (2016) -
Inhibition of sarcoplasmic Ca(2+)-ATPase increases caffeine- and halothane-induced contractures in muscle bundles of malignant hyperthermia susceptible and healthy individuals
por: Schuster, Frank, et al.
Publicado: (2005) -
Production characteristics of dutch landrace and dutch yorkshire pigs as related to their susceptibility for the halothane-induced malignant hyperthermia syndrome
por: Eikelenboom, G, et al.
Publicado: (1978) -
Putative malignant hyperthermia mutation Ca(V)1.1-R174W is insufficient to trigger a fulminant response to halothane or confer heat stress intolerance
por: Feng, Wei, et al.
Publicado: (2023) -
Update of the quality assurance (QA) results of halothane and caffeine analysis of all current participating malignant hyperthermia units
por: Fisher, Nickla, et al.
Publicado: (2014)